Table 2:
Characteristics and attribution of peripheral nervous system (PNS) disease events in SLE patients over the duration of study.
| PNS disease | Total # PNS events |
# PNS events attributed to SLE (model A) |
# PNS events attributed to SLE (model B) |
# PNS events attributed to non- SLE causes |
|---|---|---|---|---|
| Peripheral neuropathy | 66 | 25 (37.9%) | 30 (45.5%) | 36 (54.5%) |
| Mononeuropathy single or multiplex | 44 | 24 (54.5%) | 44 (100%) | 0 |
| Cranial neuropathy | 39 | 32 (82.1%) | 35 (89.7%) | 4 (10.3%) |
| Plexopathy | 2 | 0 | 0 | 2 (100%) |
| Autonomic neuropathy | 4 | 3 (75.0%) | 3 (75.0%) | 1 (25.0%) |
| Acute inflammatory demyelinating polyradiculoneuropathy (Guillain-Barré syndrome) | 3 | 3 (100%) | 3 (100%) | 0 |
| Myasthenia gravis | 3 | 1 (33.3%) | 3 (100%) | 0 |
| Total # PNS events | 161 | 88 (54.7%) | 118 (73.3%) | 43 (26.7%) |